CWMTG (n = 52)

            WMTG (n = 48)

              P^*

                       Before treatment  After treatment    P      Before treatment     After treatment       P

General clinical characteristics

Age (years)

65.2 ± 9.7

65.0 ± 9.0

0.55

Male (%)

76.4

78.9

0.21

Diabetes (%)

28.2

29.0

0.89

Hypertension (%)

39.5

38.8

0.66

Hyperlipidemia (%)

60.5

61.2

0.75

Symptoms efficacy

Markedly

59.2

56.9

0.22

Effective

24.4

20.2

0.21

Ineffectiveness

16.4

22.9

0.02

Treatment

Anti-platelet (%)

91.2

90.5

0.75

94.2

94

0.66

0.07

β-blockers (%)

65.9

62.2

0.91

64.9

64.2

0.94

0.85

statins (%)

88.4

84

0.45

88.9

86.4

0.28

0.75

ACEI/ARB (%)

57.2

56.9

0.91

61.2

60.5

0.75

0.05

Nitrates (%)

65.6

34.4

0.001

60.5

39.5

0.009

0.05

SAQ

PL

64 ± 22

54 ± 25

0.02

65 ± 23

60 ± 24

0.05

0.04

AS

40 ± 34

37 ± 31

0.05

39 ± 30

33 ± 20

0.05

0.55

AF

66 ± 27

59 ± 27

0.03

67 ± 26

61 ± 25

0.03

0.75

TS

89 ± 18

96 ± 16

0.001

88 ± 16

90 ± 17

0.004

0.05

DP

42 ± 22

48 ± 23

0.05

44 ± 24

49 ± 22

0.05

0.05